Clal Insurance Enterprises Holdings Ltd Sells 469,838 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)

Clal Insurance Enterprises Holdings Ltd lowered its position in Cellebrite DI Ltd. (NASDAQ:CLBT) by 11.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,496,109 shares of the company’s stock after selling 469,838 shares during the quarter. Clal Insurance Enterprises Holdings Ltd owned approximately 1.70% of Cellebrite DI worth $77,019,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Tower View Wealth Management LLC grew its stake in Cellebrite DI by 1.3% in the fourth quarter. Tower View Wealth Management LLC now owns 132,307 shares of the company’s stock worth $2,915,000 after purchasing an additional 1,660 shares in the last quarter. True Wind Capital Management L.P. boosted its position in Cellebrite DI by 18.2% during the 4th quarter. True Wind Capital Management L.P. now owns 13,861,007 shares of the company’s stock valued at $305,358,000 after acquiring an additional 2,130,386 shares in the last quarter. Y Intercept Hong Kong Ltd boosted its position in Cellebrite DI by 37.4% during the 4th quarter. Y Intercept Hong Kong Ltd now owns 26,811 shares of the company’s stock valued at $591,000 after acquiring an additional 7,301 shares in the last quarter. Handelsbanken Fonder AB bought a new stake in Cellebrite DI during the 4th quarter valued at $3,937,000. Finally, New York State Common Retirement Fund boosted its position in Cellebrite DI by 2.6% during the 4th quarter. New York State Common Retirement Fund now owns 189,599 shares of the company’s stock valued at $4,177,000 after acquiring an additional 4,838 shares in the last quarter. Institutional investors own 45.88% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on CLBT shares. Craig Hallum increased their target price on Cellebrite DI from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. JPMorgan Chase & Co. increased their price objective on Cellebrite DI from $24.00 to $28.00 and gave the company an “overweight” rating in a report on Tuesday, February 11th. Lake Street Capital increased their price objective on Cellebrite DI from $17.00 to $26.00 and gave the company a “buy” rating in a report on Friday, February 14th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $28.00 price objective on shares of Cellebrite DI in a report on Friday, February 14th. Eight analysts have rated the stock with a buy rating, According to MarketBeat, the company has an average rating of “Buy” and a consensus target price of $23.43.

Cellebrite DI Trading Up 0.3 %

CLBT stock opened at $18.56 on Friday. Cellebrite DI Ltd. has a 12-month low of $10.24 and a 12-month high of $26.30. The stock has a market cap of $3.82 billion, a price-to-earnings ratio of -13.35, a PEG ratio of 4.27 and a beta of 1.47. The business’s 50-day moving average is $22.31 and its 200 day moving average is $19.61.

Cellebrite DI (NASDAQ:CLBT) last released its earnings results on Thursday, February 13th. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.03). Cellebrite DI had a positive return on equity of 58.70% and a negative net margin of 70.54%. As a group, equities analysts forecast that Cellebrite DI Ltd. will post 0.3 EPS for the current fiscal year.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.